Articles by Category

Total Solar Eclipse on 22nd July Surya Utsav

Download Resources Material

Intellectual Property Rights
Oppose this Attempt to Destroy Indian Science

Amit Sengupta

10th January 2010

FOR over two years the government has made known its intention to introduce a bill in parliament, titled: “Public Funded Research and Development (Protection, Utilisation and Regulation of Intellectual Property) Bill”. The standing committee on science and technology is presently engaged in deliberating over the contents of the bill, and the bill is likely to be introduced in the next session of parliament. As the bill, if enacted, shall have far reaching consequences for scientific research in India, provisions of the bill need to be examined closely.

The genesis ...

Read more...

Last Updated on Saturday, 09 January 2010 10:33
 
February 22, 2009

 

If we look at national interest, Indian science has a stake in an open source model of innovation to bring down the cost of products. A knowledge monopoly based system of innovation may end up by making some money for the university, it will not help the Indian people at all.

Read more...

Last Updated on Saturday, 09 May 2009 15:28
Read more...
 
Bayer Sues The Indian Govt To Retain Its Monopoly Right

February 08, 2009

Why is the premier drug regulatory authority in India interested in curbing its own powers by becoming subservient to the decisions of the Patent office. Is this a result of influence that is being exerted by drug MNCs on the DCGI’s office?

Amit Sengupta


THE German Multinational company, Bayer, had been granted a patent for its drug, Sorafenib tosylate (marketed as Nexavar by the company), in India a few months back. The drug is used for the treatment of renal cell carcinoma (a type of cancer of the kidneys) and for treating advanced cases of hepatocellular carcinoma (a form of liver ...

Read more...

Last Updated on Saturday, 09 May 2009 15:29
Read more...
 
What Ashok Desai Does Not Know About James Watt (or Patents)

August 05, 2007

Prabir Purkayastha

WHEN the Mashelkar Committee’s Report was losing credibility for “lifting” the operative part of its report from a submission made to the committee, Ashok Desai, a well known economist and the consultant editor of Telegraph wrote an interesting defence of Mashelkar in his column. According to him, plagiarism was a trivial crime and the much larger issue was the content of the report. He then proceeded to give his view on Indian pharmaceutical industry and patents, which read more like a handout of a large pharmaceutical company than a serious piece.

Read more...

Last Updated on Wednesday, 14 January 2009 09:09
 
Patent Wars And The Indian Scenario

Prabir Purkayastha

THE past few months have been quite important for developments in the patents front. Most of the action has come from the US, with the US Supreme Court giving two important judgements on the scope and reach of patents. On the software front, Microsoft has started what was on the cards for quite some time –– a threat of patents war. It has claimed that the Free and Open Source Software (FOSS) community has breached 235 of its patents, a claim that Fortune magazine called as Microsoft’s declaration of war against the Free World! All in all, it shows that the patents regime is changing even in the US, which had hithert ...

Read more...

Last Updated on Wednesday, 14 January 2009 09:10
 
«StartPrev123456NextEnd»

Page 4 of 6